CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

Clinical trial NCT01966367 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01966367
Sponsor: Diane George
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bone Marrow Failure Syndrome Severe Aplastic Anemia Severe Congenital Neutropenia Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Schwachman Diamond Syndrome Primary Immunodeficiency Syndromes Acquired Immunodeficiency Syndromes Histiocytic Syndrome Familial Hemophagocytic Lymphocytosis Lymphohistiocytosis Macrophage Activation Syndrome

Start date: 2013-03-01
Primary completion: 2030-02-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.